Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Suélen Feijó Hillesheim"'
Autor:
Luiz Carlos Carneiro Pereira, Patrícia Chagas, Eduardo Costa Duarte Barbosa, Weimar Kunz Sebba Barroso, Adriana Camargo Oliveira, Suélen Feijó Hillesheim, Vitória Carolina Kohlrausch, Diego Chemello
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 11 (2024)
IntroductionAortic stiffness assessed by pulse wave velocity (PWV) is an important predictor to evaluate the risk of hypertensive patients. However, it is underutilized in clinical practice. We aimed to identify the optimal cutoff SAGE score that wou
Externí odkaz:
https://doaj.org/article/3ab49543fbf64812b36539f65260a681
Autor:
Diego Chemello, Larissa Rosa, Amanda Faria de Araujo, Pedro Cargnelutti de Araujo, Luiz Carlos Carneiro Pereira, Suélen Feijó Hillesheim, Marco Aurélio Lumertz Saffi
Publikováno v:
Jornal Vascular Brasileiro, Vol 20 (2021)
Abstract Our study describes a fatal case of phlegmasia cerulea dolens and massive venous thrombosis in a patient taking rivaroxaban regularly to treat cerebral venous sinus thrombosis. Blood tests samples were positive for lupus anticoagulant. The u
Externí odkaz:
https://doaj.org/article/77877914887344379380325f3ea23c66
Autor:
Amanda Faria de Araujo, Larissa Rosa, Suélen Feijó Hillesheim, Diego Chemello, Pedro Cargnelutti de Araujo, Marco Aurélio Lumertz Saffi, Luiz Carlos Carneiro Pereira
Publikováno v:
Jornal Vascular Brasileiro, Vol 20 (2021)
Jornal Vascular Brasileiro
Jornal Vascular Brasileiro
Our study describes a fatal case of phlegmasia cerulea dolens and massive venous thrombosis in a patient taking rivaroxaban regularly to treat cerebral venous sinus thrombosis. Blood tests samples were positive for lupus anticoagulant. The unique evo
Autor:
Suélen Feijó Hillesheim, Luiz Carlos Carneiro Pereira, Lorenzo Link Saldanha, Gabriela Vaz Pereira, Marco Aurélio Lumertz Saffi, Diego Chemello
Publikováno v:
Global Journal of Health Science. 14:71
INTRODUCTION: Treatment with Vitamin K Antagonists is already proven to be significant in reducing thromboembolic events in patients with indications for systemic anticoagulation. In the context of ambulatory adherence, the SARS-CoV2 coronavirus pand